Vala Hamidi MD
Diabetes, Lipid Metabolism, Parathyroid, Pituitary Disorders & Neuroendocrinology
Assistant Professor of Medicine
Join to View Full Profile
4168 Front StSan Diego, CA 92103
Phone+1 800-926-8273
Fax+1 888-539-8781
Dr. Hamidi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Vala Hamidi, MD, is an Endocrinology specialist located in La Jolla, CA, with subspecialties such as Diabetes, Lipid Metabolism, Parathyroid, Pituitary Disorders & Neuroendocrinology. Dr. Hamidi's education background includes a Residency in Internal Medicine from 2011 to 2014 at the New York-Presbyterian Brooklyn Methodist Hospital, a Post-Doctoral Fellowship in Diabetes Research from 2014 to 2015 at The University of Texas Health Science Center at San Antonio, and a Fellowship in Endocrinology, Diabetes, and Metabolism from 2015 to 2017 at University of Texas Health Science Center at Houston. They are currently an Assistant Professor at UC San Diego Health. Dr. Hamidi's academic contributions include numerous publications on topics regarding Diabetes and Endocrinology, including works in Diabetes Care, Cardiovascular Endocrinology & Metabolism, and Cell Reports. Medicine.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017
The University of Texas Health Science Center at San AntonioPost-Doctoral Fellowship, 2014 - 2015
New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 2011 - 2014
Shiraz University of Medical SciencesClass of 2008
Certifications & Licensure
CA State Medical License 2017 - 2026
TX State Medical License 2015 - 2019
CO State Medical License 2014 - 2015
Publications & Presentations
PubMed
- 3 citationsContinuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes.Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory
Diabetes Care. 2024-05-01 - 17 citationsTime in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?Vala Hamidi, Jeremy H Pettus
Diabetes Care. 2024-05-01 - Chronic GLP1 therapy reduces postprandial IL6 in obese humans with prediabetes.Vala Hamidi, Hongyu Wang, Vi Pham, Karla Bermudez Saint Andre, Heinrich Taegtmeyer
Cardiovascular Endocrinology & Metabolism. 2024-03-01
Press Mentions
San Diego’s Top Doctors: The Annual List, 2025September 30th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
